If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,265.00    15.00 (1.20%)
Bid:
1,250.00
Ask:
1,265.00
Spread: 15.00 (1.20%)
Market Cap: £177.10m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

17 Feb 2012 09:31

RNS Number : 6261X
Oryx International Growth Fund Ld
17 February 2012
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2011

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2011 to 31 December 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -1.26% and the FTSE All-Share TR Index (£) returned +8.39%. Against this, the Fund's net asset value rose by 3.7% to 279p per share. Whilst market conditions remain difficult, the Manager believes that there is the potential for corporate activity to occur in the Fund's quoted portfolio and there remains scope for capital appreciation in the unquoted portfolio.

 

 

Material Transactions

Since 1 October 2011, the Company has purchased for cancellation the following shares:

 

14 December 2011 a total of 584,392 ordinary shares at a gross price of £1.90 per share.

19 December 2011 a total of 5,000 ordinary shares at a gross price of £1.90 per share.

28 December 2011 a total of 5,000 ordinary shares at a gross price of £2.00 per share.

9 February 2012 a total of 53,000 ordinary shares at a gross price of £2.02 per share.

 

Material Events

There were no material events during the quarter ended 31 December 2011.

 

 

Report and Accounts

On 25 November 2011, the Company posted its Interim Report for the six months ended 30 September 2011, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2011

30 September 2011

30 June

2011

31 March 2011

31 December 2010

 

 

 

 

 

 

NAV

£2.79

£2.69

£2.96

£2.72

£2.81

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5541

 

1.5579

 

1.6055

 

1.6029

 

1.5657

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2011

 

% Net Assets

Gleeson (M.J.) Group Plc

7.00

CVS Group Plc

6.71

Redhall Group Plc

6.47

GTL Resources Plc

6.20

Augean Plc

5.47

Guinness Peat Group Plc

5.39

RPC Group Plc

5.28

Orthoproducts Ltd

5.14

Quatro Group Inc

4.99

BBA Aviation Plc

4.28

Idox Plc

4.28

Eckoh Plc

3.97

Assetco Plc

3.87

Catalyst Media Group Plc

3.51

Bavaria Industriekapital Ag

3.14

Sinclair IS Pharma Plc

3.05

Nastor Inv Ltd Zero Redeem Prefer Shares

2.71

Journey Group Plc

2.53

Bionostics Holdings Ltd

2.49

Celsis AG

2.18

85.33

 

 

The financial information for the quarter ended 31 December 2011 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUUWPUPPUBM
Date   Source Headline
23rd Sep 20165:22 pmRNSNet Asset Value(s)
1st Sep 20164:45 pmRNSHolding(s) in Company
31st Aug 20163:33 pmRNSNet Asset Value(s)
26th Aug 20162:48 pmRNSResult of AGM
25th Aug 20162:25 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Aug 20169:48 amRNSTransaction in Own Shares
19th Aug 201611:41 amRNSHolding(s) in Company
3rd Aug 20169:15 amRNSNet Asset Value(s)
28th Jul 20165:05 pmRNSNotification of Major Interest in Shares
28th Jul 20163:33 pmRNSHolding(s) in Company
26th Jul 20169:45 amRNSHolding(s) in Company
15th Jul 20167:32 amRNSHolding(s) in Company
13th Jul 20167:00 amRNSAnnual Report and Accounts and Notice of AGM
5th Jul 20161:14 pmRNSHolding(s) in Company
4th Jul 20165:01 pmRNSAnnual Financial Report
4th Jul 20168:18 amRNSHolding(s) in Company
24th Jun 201610:14 amRNSNet Asset Value(s)
3rd Jun 20161:36 pmRNSHolding(s) in Company
27th May 20163:08 pmRNSNet Asset Value(s)
10th May 20165:30 pmRNSTransactions in a Close Period
10th May 20165:30 pmRNSTransaction in Own Shares
28th Apr 201612:22 pmRNSNet Asset Value(s)
29th Mar 20169:37 amRNSNet Asset Value(s)
23rd Feb 20163:36 pmRNSNet Asset Value(s)
18th Feb 201611:07 amRNSForm 8.3 - Tangent Communications plc
28th Jan 20167:00 amRNSDisclosure of Home Member State
25th Jan 201612:19 pmRNSNet Asset Value(s)
18th Jan 201612:41 pmRNSHolding(s) in Company
18th Jan 201611:56 amRNSHolding(s) in Company
15th Jan 20163:11 pmRNSHolding(s) in Company
13th Jan 20169:17 amRNSHolding(s) in Company
18th Dec 20158:02 amRNSNet Asset Value(s)
10th Dec 20157:00 amRNSTR-1: Notification Of Major Interest In Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
3rd Dec 201512:28 pmRNSHolding(s) in Company
27th Nov 20153:44 pmRNSHolding(s) in Company - Replacement
24th Nov 20153:17 pmRNSHolding(s) in Company
24th Nov 201510:49 amRNSNet Asset Value(s)
20th Nov 20157:00 amRNSHalf Yearly Report
16th Nov 20156:00 pmRNSPortfolio Update
14th Oct 201512:07 pmRNSNet Asset Value(s)
1st Oct 201511:51 amRNSHolding(s) in Company Replacement
30th Sep 20156:08 pmRNSHolding(s) in Company
21st Sep 201510:38 amRNSNet Asset Value(s)
18th Sep 20154:37 pmRNSHolding(s) in Company
1st Sep 20156:00 pmRNSTransaction in Own Shares
1st Sep 20155:21 pmRNSHolding(s) in Company
27th Aug 201512:48 pmRNSNet Asset Value(s)
25th Aug 20152:15 pmRNSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 20151:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.